Response to Letter to the Editor on “Rivaroxaban Use for Thromboprophylaxis Is Associated With Early Periprosthetic Joint Infection”
To the Editor: We would like to thank the authors for their input regarding our article entitled “Rivaroxaban Use for Thrombosis Prophylaxis Is Associated With Early Periprosthetic Joint Infection” [1]. As the authors noted, in the RECORD randomized controlled trials, no statistical differences in s...
| Autores Principales: | , , , , |
|---|---|
| Formato: | Revisión (Review) |
| Lenguaje: | Inglés (English) |
| Publicado: |
The Journal of Arthroplasty
2016
|
| Materias: | |
| Acceso en línea: | https://repository.urosario.edu.co/handle/10336/25671 https://doi.org/10.1016/j.arth.2016.05.017 |